You are here
Minnetronix Medical, Inc.
http://www.minnetronixmedical.com
UEI: MKKQLNN6GSE5
# of Employees: 300
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Automation of Extracorporeal Filtration of Subarachnoid Hemorrhage via Spinal Catheter
Amount: $1,895,299.00ABSTRACT Aneurysmal subarachnoid hemorrhage (SAH) is a devastating neurological condition occurring as the result of a ruptured cerebral aneurysm. The mean incidence is 11 people per 100,000 populatio ...
SBIRPhase II2020Department of Health and Human Services National Institutes of Health -
Automation of Extracorporeal Filtration of Subarachnoid Hemorrhage via Spinal Catheter
Amount: $561,439.00ABSTRACT Aneurysmal subarachnoid hemorrhageSAHis a devastating neurological condition occurring as the result of a ruptured cerebral aneurysmThe mean incidence ispeople perpopulation and an estimatedc ...
SBIRPhase I2019Department of Health and Human Services National Institutes of Health -
Validation of a Novel Fungicidal Approach for Cryptococcal Meningitis
Amount: $2,907,798.00ABSTRACT When Cryptococcus is manifested as cryptococcal meningitis (CM), it creates a large burden of mortality and morbidity to the patient and is very difficult for the clinician to treat. There ar ...
STTRPhase II2018Department of Health and Human Services National Institutes of Health -
Validation of Novel Therapeutic Approach for Leptomeningeal Metastases
Amount: $1,949,379.00ABSTRACT Leptomeningeal Metastases (LM) is a condition in which tumor cells from a primary tumor metastasize, invade the subarachnoid space (SAS) and spread throughout the cerebrospinal fluid (CSF), r ...
STTRPhase II2018Department of Health and Human Services National Institutes of Health -
Validation of Novel Therapeutic Approach for Cryptococcal Meningitis
Amount: $1,486,918.00Validation of a Novel Therapeutic Approach for Cryptococcal Meningitis PILadShivanand and McCabeAaron Project Summary When Cryptococcus is manifested as cryptococcal meningitisCMit creates a large bur ...
STTRPhase II2017Department of Health and Human Services National Institutes of Health -
Directed Chemotherapy Delivery for Leptomeningeal Metastases
Amount: $224,970.00DESCRIPTION provided by applicant Directed Chemotherapy Delivery for Leptomeningeal Metastases PI Lad Shivanand and McCabe Aaron Project Summary Leptomeningeal Metastases LM is a condition in ...
STTRPhase I2016Department of Health and Human Services National Institutes of Health -
Directed Antifungal Therapy for HIV-associated Cryptococcal Meningitis
Amount: $224,976.00DESCRIPTION provided by applicant Directed Antifungal Therapy for HIV associated Cryptococcal Meningitis PI Lad Shivanand and McCabe Aaron Project Summary Cryptococcosis is an important systemic ...
STTRPhase I2015Department of Health and Human Services National Institutes of Health -
Development of a Novel Therapeutic Approach for Cryptococcal Meningitis
Amount: $224,917.00DESCRIPTION provided by applicant When Cryptococcus is manifested as Cryptococcal meningitis CM it creates a large burden of mortality and morbidity to the patient and is very difficult for the ...
STTRPhase I2015Department of Health and Human Services National Institutes of Health -
Transcutaneous Energy Transmission System for Fully Implantable VADs
Amount: $1,567,771.00DESCRIPTION provided by applicant Mechanical circulatory support devices have become increasingly common in the treatment of end stage heart failure primarily in the form of the Left Ventricular A ...
SBIRPhase II2014Department of Health and Human Services National Institutes of Health -
Development of an Infant VAD System for Long Term Uni- and Bi-ventricular Support
Amount: $1,501,784.00DESCRIPTION (provided by applicant): Development of an Infant VAD System for Long Term Uni- and Bi-ventricular Support Project Summary This objective of the project is to develop a Ventricular Assist ...
SBIRPhase II2012Department of Health and Human Services National Institutes of Health
